POZEN Inc.
POZEN IND and NDA for Treximet Sumatriptan/Naproxen Sodium Transferred to GlaxoSmithKline
Published in Medical Letter on the CDC and FDA, June 8th, 2008
The FDA approved Treximet for the acute treatment of migraine attacks, with or without aura, in adults on April 15, 2008. Treximet will be commercialized by GlaxoSmithKline.
Keywords: Biotechnology, Drug Development, Drugs, GlaxoSmithKline, Naproxen Sodium, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Regulatory Actions, Selective Serotonin Agonist, Sumatriptan, Therapy,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cardiovascular Disease
When It comes to Matters of the Heart, Almonds Are a Multi-Tasker - Colon Cancer
New findings in colon cancer described from University of Texas - HemoBioTech
HemoBioTech Indicates ''HEMOTECH'' Commercial Development Strategy is Unaffected by Recent FDA/NIH Workshop on Blood Substitutes - Life Sciences
Study results from H.K. Park et al provide new insights into life sciences - Life Sciences
Study results from M. Brandt and colleagues in the area of life sciences published - Asthma Clinical Trial
Research from D.G. Woodside and colleagues has provided new data on asthma clinical trial - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
